Polycystic Ovary Syndrome Market, Global Outlook and Forecast 2022-2028

March 2022 | 110 pages | ID: P65045D9FDAAEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Polycystic Ovary Syndrome in Global, including the following market information:

Global Polycystic Ovary Syndrome Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Polycystic Ovary Syndrome market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Diuretics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Polycystic Ovary Syndrome include Abbott Laboratories, Addex therapeutics, Himalaya, Astellas Pharma, AstraZeneca, Ava Science, Bayer, Bristol-Myers Squibb and Theralogix, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Polycystic Ovary Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Polycystic Ovary Syndrome Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Polycystic Ovary Syndrome Market Segment Percentages, by Type, 2021 (%)

• Diuretics
• Insulin sensitizing agents
• Antiandrogens
• Anti-depressants
• Ornithine decarboxylase inhibitors

Global Polycystic Ovary Syndrome Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Polycystic Ovary Syndrome Market Segment Percentages, by Application, 2021 (%)

• Hospital pharmacies
• Drug stores
• Retail pharmacies

Global Polycystic Ovary Syndrome Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Polycystic Ovary Syndrome Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Polycystic Ovary Syndrome revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Polycystic Ovary Syndrome revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• Addex therapeutics
• Himalaya
• Astellas Pharma
• AstraZeneca
• Ava Science
• Bayer
• Bristol-Myers Squibb
• Theralogix
• Ferring Pharmaceuticals
• Teva Pharmaceutical
• GSK
• Sneha Natura
• Jarrow Formulas
• Merck
• Millendo Therapeutics
• MyOva
• Novartis
• Ogeda
• PCOS Diva
• Pharmasure
• Salveo Lifecare

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Polycystic Ovary Syndrome Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Polycystic Ovary Syndrome Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL POLYCYSTIC OVARY SYNDROME OVERALL MARKET SIZE

2.1 Global Polycystic Ovary Syndrome Market Size: 2021 VS 2028
2.2 Global Polycystic Ovary Syndrome Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Polycystic Ovary Syndrome Players in Global Market
3.2 Top Global Polycystic Ovary Syndrome Companies Ranked by Revenue
3.3 Global Polycystic Ovary Syndrome Revenue by Companies
3.4 Top 3 and Top 5 Polycystic Ovary Syndrome Companies in Global Market, by Revenue in 2021
3.5 Global Companies Polycystic Ovary Syndrome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Polycystic Ovary Syndrome Players in Global Market
  3.6.1 List of Global Tier 1 Polycystic Ovary Syndrome Companies
  3.6.2 List of Global Tier 2 and Tier 3 Polycystic Ovary Syndrome Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Polycystic Ovary Syndrome Market Size Markets, 2021 & 2028
  4.1.2 Diuretics
  4.1.3 Insulin sensitizing agents
  4.1.4 Antiandrogens
  4.1.5 Anti-depressants
  4.1.6 Ornithine decarboxylase inhibitors
4.2 By Type - Global Polycystic Ovary Syndrome Revenue & Forecasts
  4.2.1 By Type - Global Polycystic Ovary Syndrome Revenue, 2017-2022
  4.2.2 By Type - Global Polycystic Ovary Syndrome Revenue, 2023-2028
  4.2.3 By Type - Global Polycystic Ovary Syndrome Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Polycystic Ovary Syndrome Market Size, 2021 & 2028
  5.1.2 Hospital pharmacies
  5.1.3 Drug stores
  5.1.4 Retail pharmacies
5.2 By Application - Global Polycystic Ovary Syndrome Revenue & Forecasts
  5.2.1 By Application - Global Polycystic Ovary Syndrome Revenue, 2017-2022
  5.2.2 By Application - Global Polycystic Ovary Syndrome Revenue, 2023-2028
  5.2.3 By Application - Global Polycystic Ovary Syndrome Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Polycystic Ovary Syndrome Market Size, 2021 & 2028
6.2 By Region - Global Polycystic Ovary Syndrome Revenue & Forecasts
  6.2.1 By Region - Global Polycystic Ovary Syndrome Revenue, 2017-2022
  6.2.2 By Region - Global Polycystic Ovary Syndrome Revenue, 2023-2028
  6.2.3 By Region - Global Polycystic Ovary Syndrome Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Polycystic Ovary Syndrome Revenue, 2017-2028
  6.3.2 US Polycystic Ovary Syndrome Market Size, 2017-2028
  6.3.3 Canada Polycystic Ovary Syndrome Market Size, 2017-2028
  6.3.4 Mexico Polycystic Ovary Syndrome Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Polycystic Ovary Syndrome Revenue, 2017-2028
  6.4.2 Germany Polycystic Ovary Syndrome Market Size, 2017-2028
  6.4.3 France Polycystic Ovary Syndrome Market Size, 2017-2028
  6.4.4 U.K. Polycystic Ovary Syndrome Market Size, 2017-2028
  6.4.5 Italy Polycystic Ovary Syndrome Market Size, 2017-2028
  6.4.6 Russia Polycystic Ovary Syndrome Market Size, 2017-2028
  6.4.7 Nordic Countries Polycystic Ovary Syndrome Market Size, 2017-2028
  6.4.8 Benelux Polycystic Ovary Syndrome Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Polycystic Ovary Syndrome Revenue, 2017-2028
  6.5.2 China Polycystic Ovary Syndrome Market Size, 2017-2028
  6.5.3 Japan Polycystic Ovary Syndrome Market Size, 2017-2028
  6.5.4 South Korea Polycystic Ovary Syndrome Market Size, 2017-2028
  6.5.5 Southeast Asia Polycystic Ovary Syndrome Market Size, 2017-2028
  6.5.6 India Polycystic Ovary Syndrome Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Polycystic Ovary Syndrome Revenue, 2017-2028
  6.6.2 Brazil Polycystic Ovary Syndrome Market Size, 2017-2028
  6.6.3 Argentina Polycystic Ovary Syndrome Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Polycystic Ovary Syndrome Revenue, 2017-2028
  6.7.2 Turkey Polycystic Ovary Syndrome Market Size, 2017-2028
  6.7.3 Israel Polycystic Ovary Syndrome Market Size, 2017-2028
  6.7.4 Saudi Arabia Polycystic Ovary Syndrome Market Size, 2017-2028
  6.7.5 UAE Polycystic Ovary Syndrome Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Polycystic Ovary Syndrome Major Product Offerings
  7.1.4 Abbott Laboratories Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.1.5 Abbott Laboratories Key News
7.2 Addex therapeutics
  7.2.1 Addex therapeutics Corporate Summary
  7.2.2 Addex therapeutics Business Overview
  7.2.3 Addex therapeutics Polycystic Ovary Syndrome Major Product Offerings
  7.2.4 Addex therapeutics Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.2.5 Addex therapeutics Key News
7.3 Himalaya
  7.3.1 Himalaya Corporate Summary
  7.3.2 Himalaya Business Overview
  7.3.3 Himalaya Polycystic Ovary Syndrome Major Product Offerings
  7.3.4 Himalaya Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.3.5 Himalaya Key News
7.4 Astellas Pharma
  7.4.1 Astellas Pharma Corporate Summary
  7.4.2 Astellas Pharma Business Overview
  7.4.3 Astellas Pharma Polycystic Ovary Syndrome Major Product Offerings
  7.4.4 Astellas Pharma Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.4.5 Astellas Pharma Key News
7.5 AstraZeneca
  7.5.1 AstraZeneca Corporate Summary
  7.5.2 AstraZeneca Business Overview
  7.5.3 AstraZeneca Polycystic Ovary Syndrome Major Product Offerings
  7.5.4 AstraZeneca Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.5.5 AstraZeneca Key News
7.6 Ava Science
  7.6.1 Ava Science Corporate Summary
  7.6.2 Ava Science Business Overview
  7.6.3 Ava Science Polycystic Ovary Syndrome Major Product Offerings
  7.6.4 Ava Science Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.6.5 Ava Science Key News
7.7 Bayer
  7.7.1 Bayer Corporate Summary
  7.7.2 Bayer Business Overview
  7.7.3 Bayer Polycystic Ovary Syndrome Major Product Offerings
  7.7.4 Bayer Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.7.5 Bayer Key News
7.8 Bristol-Myers Squibb
  7.8.1 Bristol-Myers Squibb Corporate Summary
  7.8.2 Bristol-Myers Squibb Business Overview
  7.8.3 Bristol-Myers Squibb Polycystic Ovary Syndrome Major Product Offerings
  7.8.4 Bristol-Myers Squibb Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.8.5 Bristol-Myers Squibb Key News
7.9 Theralogix
  7.9.1 Theralogix Corporate Summary
  7.9.2 Theralogix Business Overview
  7.9.3 Theralogix Polycystic Ovary Syndrome Major Product Offerings
  7.9.4 Theralogix Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.9.5 Theralogix Key News
7.10 Ferring Pharmaceuticals
  7.10.1 Ferring Pharmaceuticals Corporate Summary
  7.10.2 Ferring Pharmaceuticals Business Overview
  7.10.3 Ferring Pharmaceuticals Polycystic Ovary Syndrome Major Product Offerings
  7.10.4 Ferring Pharmaceuticals Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.10.5 Ferring Pharmaceuticals Key News
7.11 Teva Pharmaceutical
  7.11.1 Teva Pharmaceutical Corporate Summary
  7.11.2 Teva Pharmaceutical Business Overview
  7.11.3 Teva Pharmaceutical Polycystic Ovary Syndrome Major Product Offerings
  7.11.4 Teva Pharmaceutical Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.11.5 Teva Pharmaceutical Key News
7.12 GSK
  7.12.1 GSK Corporate Summary
  7.12.2 GSK Business Overview
  7.12.3 GSK Polycystic Ovary Syndrome Major Product Offerings
  7.12.4 GSK Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.12.5 GSK Key News
7.13 Sneha Natura
  7.13.1 Sneha Natura Corporate Summary
  7.13.2 Sneha Natura Business Overview
  7.13.3 Sneha Natura Polycystic Ovary Syndrome Major Product Offerings
  7.13.4 Sneha Natura Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.13.5 Sneha Natura Key News
7.14 Jarrow Formulas
  7.14.1 Jarrow Formulas Corporate Summary
  7.14.2 Jarrow Formulas Business Overview
  7.14.3 Jarrow Formulas Polycystic Ovary Syndrome Major Product Offerings
  7.14.4 Jarrow Formulas Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.14.5 Jarrow Formulas Key News
7.15 Merck
  7.15.1 Merck Corporate Summary
  7.15.2 Merck Business Overview
  7.15.3 Merck Polycystic Ovary Syndrome Major Product Offerings
  7.15.4 Merck Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.15.5 Merck Key News
7.16 Millendo Therapeutics
  7.16.1 Millendo Therapeutics Corporate Summary
  7.16.2 Millendo Therapeutics Business Overview
  7.16.3 Millendo Therapeutics Polycystic Ovary Syndrome Major Product Offerings
  7.16.4 Millendo Therapeutics Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.16.5 Millendo Therapeutics Key News
7.17 MyOva
  7.17.1 MyOva Corporate Summary
  7.17.2 MyOva Business Overview
  7.17.3 MyOva Polycystic Ovary Syndrome Major Product Offerings
  7.17.4 MyOva Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.17.5 MyOva Key News
7.18 Novartis
  7.18.1 Novartis Corporate Summary
  7.18.2 Novartis Business Overview
  7.18.3 Novartis Polycystic Ovary Syndrome Major Product Offerings
  7.18.4 Novartis Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.18.5 Novartis Key News
7.19 Ogeda
  7.19.1 Ogeda Corporate Summary
  7.19.2 Ogeda Business Overview
  7.19.3 Ogeda Polycystic Ovary Syndrome Major Product Offerings
  7.19.4 Ogeda Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.19.5 Ogeda Key News
7.20 PCOS Diva
  7.20.1 PCOS Diva Corporate Summary
  7.20.2 PCOS Diva Business Overview
  7.20.3 PCOS Diva Polycystic Ovary Syndrome Major Product Offerings
  7.20.4 PCOS Diva Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.20.5 PCOS Diva Key News
7.21 Pharmasure
  7.21.1 Pharmasure Corporate Summary
  7.21.2 Pharmasure Business Overview
  7.21.3 Pharmasure Polycystic Ovary Syndrome Major Product Offerings
  7.21.4 Pharmasure Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.21.5 Pharmasure Key News
7.22 Salveo Lifecare
  7.22.1 Salveo Lifecare Corporate Summary
  7.22.2 Salveo Lifecare Business Overview
  7.22.3 Salveo Lifecare Polycystic Ovary Syndrome Major Product Offerings
  7.22.4 Salveo Lifecare Polycystic Ovary Syndrome Revenue in Global Market (2017-2022)
  7.22.5 Salveo Lifecare Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Polycystic Ovary Syndrome Market Opportunities & Trends in Global Market
Table 2. Polycystic Ovary Syndrome Market Drivers in Global Market
Table 3. Polycystic Ovary Syndrome Market Restraints in Global Market
Table 4. Key Players of Polycystic Ovary Syndrome in Global Market
Table 5. Top Polycystic Ovary Syndrome Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Polycystic Ovary Syndrome Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Polycystic Ovary Syndrome Revenue Share by Companies, 2017-2022
Table 8. Global Companies Polycystic Ovary Syndrome Product Type
Table 9. List of Global Tier 1 Polycystic Ovary Syndrome Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Polycystic Ovary Syndrome Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Polycystic Ovary Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Polycystic Ovary Syndrome Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Polycystic Ovary Syndrome Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Polycystic Ovary Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Polycystic Ovary Syndrome Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Polycystic Ovary Syndrome Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Polycystic Ovary Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Polycystic Ovary Syndrome Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Polycystic Ovary Syndrome Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Polycystic Ovary Syndrome Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Polycystic Ovary Syndrome Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Polycystic Ovary Syndrome Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Polycystic Ovary Syndrome Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Polycystic Ovary Syndrome Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Polycystic Ovary Syndrome Product Offerings
Table 32. Abbott Laboratories Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 33. Addex therapeutics Corporate Summary
Table 34. Addex therapeutics Polycystic Ovary Syndrome Product Offerings
Table 35. Addex therapeutics Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 36. Himalaya Corporate Summary
Table 37. Himalaya Polycystic Ovary Syndrome Product Offerings
Table 38. Himalaya Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 39. Astellas Pharma Corporate Summary
Table 40. Astellas Pharma Polycystic Ovary Syndrome Product Offerings
Table 41. Astellas Pharma Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 42. AstraZeneca Corporate Summary
Table 43. AstraZeneca Polycystic Ovary Syndrome Product Offerings
Table 44. AstraZeneca Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 45. Ava Science Corporate Summary
Table 46. Ava Science Polycystic Ovary Syndrome Product Offerings
Table 47. Ava Science Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 48. Bayer Corporate Summary
Table 49. Bayer Polycystic Ovary Syndrome Product Offerings
Table 50. Bayer Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 51. Bristol-Myers Squibb Corporate Summary
Table 52. Bristol-Myers Squibb Polycystic Ovary Syndrome Product Offerings
Table 53. Bristol-Myers Squibb Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 54. Theralogix Corporate Summary
Table 55. Theralogix Polycystic Ovary Syndrome Product Offerings
Table 56. Theralogix Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 57. Ferring Pharmaceuticals Corporate Summary
Table 58. Ferring Pharmaceuticals Polycystic Ovary Syndrome Product Offerings
Table 59. Ferring Pharmaceuticals Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 60. Teva Pharmaceutical Corporate Summary
Table 61. Teva Pharmaceutical Polycystic Ovary Syndrome Product Offerings
Table 62. Teva Pharmaceutical Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 63. GSK Corporate Summary
Table 64. GSK Polycystic Ovary Syndrome Product Offerings
Table 65. GSK Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 66. Sneha Natura Corporate Summary
Table 67. Sneha Natura Polycystic Ovary Syndrome Product Offerings
Table 68. Sneha Natura Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 69. Jarrow Formulas Corporate Summary
Table 70. Jarrow Formulas Polycystic Ovary Syndrome Product Offerings
Table 71. Jarrow Formulas Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 72. Merck Corporate Summary
Table 73. Merck Polycystic Ovary Syndrome Product Offerings
Table 74. Merck Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 75. Millendo Therapeutics Corporate Summary
Table 76. Millendo Therapeutics Polycystic Ovary Syndrome Product Offerings
Table 77. Millendo Therapeutics Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 78. MyOva Corporate Summary
Table 79. MyOva Polycystic Ovary Syndrome Product Offerings
Table 80. MyOva Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 81. Novartis Corporate Summary
Table 82. Novartis Polycystic Ovary Syndrome Product Offerings
Table 83. Novartis Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 84. Ogeda Corporate Summary
Table 85. Ogeda Polycystic Ovary Syndrome Product Offerings
Table 86. Ogeda Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 87. PCOS Diva Corporate Summary
Table 88. PCOS Diva Polycystic Ovary Syndrome Product Offerings
Table 89. PCOS Diva Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 90. Pharmasure Corporate Summary
Table 91. Pharmasure Polycystic Ovary Syndrome Product Offerings
Table 92. Pharmasure Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)
Table 93. Salveo Lifecare Corporate Summary
Table 94. Salveo Lifecare Polycystic Ovary Syndrome Product Offerings
Table 95. Salveo Lifecare Polycystic Ovary Syndrome Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Polycystic Ovary Syndrome Segment by Type in 2021
Figure 2. Polycystic Ovary Syndrome Segment by Application in 2021
Figure 3. Global Polycystic Ovary Syndrome Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Polycystic Ovary Syndrome Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Polycystic Ovary Syndrome Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Polycystic Ovary Syndrome Revenue in 2021
Figure 8. By Type - Global Polycystic Ovary Syndrome Revenue Market Share, 2017-2028
Figure 9. By Application - Global Polycystic Ovary Syndrome Revenue Market Share, 2017-2028
Figure 10. By Region - Global Polycystic Ovary Syndrome Revenue Market Share, 2017-2028
Figure 11. By Country - North America Polycystic Ovary Syndrome Revenue Market Share, 2017-2028
Figure 12. US Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Polycystic Ovary Syndrome Revenue Market Share, 2017-2028
Figure 16. Germany Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 17. France Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Polycystic Ovary Syndrome Revenue Market Share, 2017-2028
Figure 24. China Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 28. India Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Polycystic Ovary Syndrome Revenue Market Share, 2017-2028
Figure 30. Brazil Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Polycystic Ovary Syndrome Revenue Market Share, 2017-2028
Figure 33. Turkey Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Polycystic Ovary Syndrome Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Addex therapeutics Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Himalaya Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Astellas Pharma Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AstraZeneca Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Ava Science Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bayer Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bristol-Myers Squibb Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Theralogix Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Ferring Pharmaceuticals Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Teva Pharmaceutical Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. GSK Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Sneha Natura Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Jarrow Formulas Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Merck Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Millendo Therapeutics Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. MyOva Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Novartis Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Ogeda Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. PCOS Diva Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Pharmasure Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Salveo Lifecare Polycystic Ovary Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)